Top Markets
Coin of the day
Orexo AB Orexo AB

Orexo AB

ORX
Pozycja w akcjach #24895
Orexo AB (publ), a specialty pharmaceutical company, develops and... Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 to treat anaphylaxis with powder-based epinephrine; and OX-MPI for the treatment of endometriosis. Its digital therapies include deprexis for the treatment of depression; vorvida for alcohol management; and modia for opioid use disorder. The company has a collaboration agreement with Abera Bioscience AB to develop nasal powder vaccines based on the AmorphOX technology. Orexo AB (publ) was founded in 1994 and is headquartered in Uppsala, Sweden.
Cena akcji
$1.57
Kapitalizacja rynkowa
$55.01M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
-28.94%
Kraj
SE
Handel Orexo AB (ORX)

Kategoria

Historia ceny akcji dla Orexo AB (ORX)
Najwyższa cena zamknięcia: $1.66 dnia 2026-08-01

Najniższa cena zamknięcia: $10.87 dnia 2005-11-01
Historia cen akcji firmy Orexo AB od 2005 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -0.37%
2025 71.17%
2024 1.53%
2023 -16.60%
2022 -53.35%
2021 -27.52%
2020 -16.22%
2019 -4.07%
2018 41.00%
2017 22.89%
2016 -47.52%
2015 -55.53%
2014 -33.94%
2013 226.23%
2012 110.17%
2011 -35.82%
2010 15.15%
2009 9.60%
2008 -38.49%
2007 -59.09%
2006 46.28%
2005 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$60.43 66.43%
US
$51.33 72.67%
SE
$191.80 42.01%
FR
$119.82 68.80%
US
$0.72 -27.55%
HK